SPS
ENFN

Susquehanna Portfolio Strategies’s Enfusion, Inc. ENFN Stock Holding History

Susquehanna Portfolio Strategies’s Portfolio ENFN Stock Details ENFN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-11,623
Closed -$113K – 981
2023
Q4 		$113K Buy
+11,623
New +$109K ﹤0.01% 971

Other funds holding ENFN

FMC
FTV Management Company San Francisco, California $541M AUM 34.37% 1-Year Est. Return
IC
Iconiq Capital San Francisco, California $4.46B AUM 22.86% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACM
Ararat Capital Management Westport, Connecticut $178M AUM 26.61% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
1WCM
12 West Capital Management New York $592M AUM 40.75% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Susquehanna Portfolio Strategies's ENFN Position: Q1 2024 in Review

Susquehanna Portfolio Strategies sold out of Enfusion, Inc. (ENFN) in Q1 2024, closing a stake of 11,623 shares — an estimated $113K sold.

Susquehanna Portfolio Strategies first reported a position in ENFN in Q4 2023 and held it in 1 quarter. The position peaked at $113K in Q4 2023. 95 funds tracked by Wall St. Rank hold ENFN as of Q1 2024.

  • Susquehanna Portfolio Strategies reported no remaining Enfusion, Inc. position as of Q1 2024 after selling out during the quarter.
  • Susquehanna Portfolio Strategies sold 11,623 Enfusion, Inc. shares in Q1 2024, an estimated $113K.
  • Susquehanna Portfolio Strategies first reported a position in Enfusion, Inc. in Q4 2023 and held it in 1 quarter.
  • Susquehanna Portfolio Strategies's Enfusion, Inc. position peaked at $113K in Q4 2023.
  • 95 funds tracked by Wall St. Rank held Enfusion, Inc. as of Q1 2024.

Based on Susquehanna Portfolio Strategies's 13F filing for Q1 2024, filed 7 May 2024.